Facilitating Success For Follow On Biologics, 24-25 September 2012, London, UK
�As biopharmaceutical patents are beginning to expire, biosimilar products are starting to enter the marketplace. To date the EMEA has approved 14 biosimilars for use in the EU and has issued an established regulatory pathway for biosimilar app..
Original Article: Facilitating Success For Follow On Biologics, 24-25 September 2012, London, UK
NEXT ARTICLE